Cécile Bonvoisin, MSc, serves as Senior Vice President, CMC and Manufacturing of Hemab. She brings more than 20 years of strong operational experience in the pharmaceutical industry, especially in drug substance and drug product development for small molecules, biochemical and biologic products. She started her career at GlaxoSmithKline and joined from Sanofi, where she was the Global Head of Clinical Injectables Manufacturing within Biologics CMC. She also held positions in manufacturing and commercial organizations, leading international teams and strengthened her strategic thinking skills as the “attaché” of the Sanofi ExCom member in charge of Manufacturing and Quality, Supply Chain and EHS global functions. She earned a Master’s Degree in Engineering and an MSc in Process Engineering from the National Engineering School of Chemical Engineering in Toulouse, France.